Kagan, Soai win Nobel Chemistry Prize for chiral molecule research

Henri Kagan of France and Kenso Soai of Japan have been recognized with the Nobel Prize in Chemistry for their pioneering research into chiral molecules—compounds that exist in mirror-image forms, much like left and right hands. Their work has fundamentally advanced the field of asymmetric synthesis, the process by which chemists can selectively produce one molecular form over its mirror image, a capability with far-reaching applications across pharmaceutical and industrial chemistry.

Chiral molecules play a crucial role in drug development and biological processes. Many pharmaceuticals exist in chiral forms, with one version producing the desired therapeutic effect while the mirror image may prove ineffective or harmful. Kagan and Soai's methodologies have enabled chemists to manufacture these precise molecular configurations with unprecedented reliability and efficiency.

The Nobel committee highlighted how their innovations have transformed chemical manufacturing, particularly in the production of medications and other compounds where molecular handedness is critical. Their contributions have provided chemists with powerful tools to control chemical reactions at the molecular level, opening new possibilities for medical research and industrial applications.

The chemistry prize is among the most prestigious international scientific recognitions, awarded annually by the Royal Swedish Academy of Sciences to researchers who have made outstanding discoveries in the field. Kagan and Soai's selection underscores the global importance of their decades of research into one of chemistry's most elegant and practically significant challenges.